AMENDMENT NO. 3 TO INTERIM PRODUCT SUPPLY AGREEMENTInterim Product Supply Agreement • November 22nd, 2022 • Legend Biotech Corp • Pharmaceutical preparations
This Amendment No. 3 to the Interim Product Supply Agreement (this “Amendment”) is made and effective as of November 16, 2022 (the “Amendment Effective Date”), by and among Legend Biotech USA Inc., a Delaware corporation (“Legend”), and Janssen Pharmaceuticals, Inc., a Pennsylvania corporation (“JPI”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.
AMENDMENT NO. 2 TO INTERIM PRODUCT SUPPLY AGREEMENTInterim Product Supply Agreement • November 22nd, 2022 • Legend Biotech Corp • Pharmaceutical preparations
This Amendment No. 2 to the Interim Product Supply Agreement (this “Amendment”) is made and effective as of October 17, 2022 (the “Amendment Effective Date”), by and among Legend Biotech USA Inc., a Delaware corporation (“Legend”), and Janssen Pharmaceuticals, Inc., a Pennsylvania corporation (“JPI”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.
